1.. Introduction {#S0001}
================

The advancement of new materials built on polysaccharides is due to their benefits as low cost, freely available, biodegradable, non-toxic and sustainability. Biopolymers like sodium alginate, pectin and numerous others have been used in the field of GRDD. Sodium alginate, the sodium salt of alginic acid, is a biodegradable non-toxic naturally occurring macromolecule hydrate and swells in water but in acidic environment it produces gel after protonation.\[[@CIT0001]\] Alginate consists of linear copolymers of 1, 4-glycosidically linked β-D-mannuronic acid and α-L-guluronic acid. Sodium alginate, a pH sensitive polymer stable at acidic pH but unstable in alkaline medium because at higher pH a rapid dissolution occur that limits its application and can be crosslinked by physical and chemical mechanisms. Mono and divalent cations (sodium and calcium) can be used for crosslinking of sodium alginate to form three dimensional gel network.\[[@CIT0002]\] Hydroxypropyl methyl cellulose K100M (HPMC K100M) a hydrophilic polymer sustained the release of drug by increasing the viscosity of gel layer. HPMC K100M releases the drug from gel barrier by diffusion process.\[[@CIT0004]\]

Previously reported rafts such as alginate rafts of gaviscon liquid do not neutralize the gastric acid but inside the raft high pH was maintained for an extended period of time. Hampson et al. reported the alginate rafts and their various parameters used for the characterization such as raft resilience or resistance and buoyancy.\[[@CIT0005]\] The addition of antacids such as aluminum hydroxide have negative effect on structure and strength of raft but calcium carbonate have positive effect on raft thickness and strength. Hampson et al. reported the effect of antacid on raft structure and strength.\[[@CIT0006]\] In 2014 Jang et al. develop the risedronate sodium raft for reduction of esophageal irritation by using sodium alginate as raft forming polymer.\[[@CIT0007]\] Raft of curcumin-eudragit by using sodium alginate as gelling polymer and calcium carbonate for generating CO~2~ and Ca^2+^ reported by Kerdsakundee et al. \[[@CIT0008]\]

The objective of this research work is to develop and characterize alginate rafts for the treatment of peptic ulcer along with reflux disorders. *In vitro* modified balance method will be developed for measurement of strength of raft. Modified paddle mixer apparatus is developed for the determination of raft resilience. Acid neutralizing and buffering capacity of sodium bicarbonate and citric acid are measured by modified USP type II dissolution apparatus and effect of calcium on strength of raft is determined. The developed formulations are further characterized by determining the floating lag time (FLT) and total floating time (TFT) of raft. *In vitro* dissolution studies are performed to check the release pattern of pantoprazole sodium sesquihydrate (PSS). Fourier transform infrared spectroscopy (FTIR) studies are performed to check the interactions between drug, polymers and other excipients. X-ray diffractometry (XRD) is used to check the crystalline or amorphous nature of the drug and polymers and differential scanning calorimetry (DSC) is used to check the thermal behavior of drug and polymers.

2.. Experimental {#S0002}
================

2.1.. Materials {#S0003}
---------------

PSS was obtained as a gift sample from Shrooq Pharmaceuticals Pvt. Ltd. Lahore, Pakistan. Sodium alginate and HPMC K100M were of analytical grade and purchased from Sigma--Aldrich Chemie Gmbh Germany. Sodium bicarbonate, citric acid, and calcium carbonate were obtained from KGaA Darmstadt, Germany. Pepsin was obtained from Scharlau Barcelona, Spain. Double distilled water was used in whole study and other chemicals/reagents used was of analytical grade.

2.2.. Methods {#S0004}
-------------

### 2.2.1.. Box behnken design {#S0005}

Box behnken response surface designs are used to require three levels, coded as −1, 0, and +1. Box behnken design (BBD) was used \[[@CIT0009]\] for optimization of tablets having three independent variables and three dependent variables using design expert (version 7.1 state-ease Inc., Minneapolis, MN). Independent variables were percentages of sodium alginate (*X* ~1~), HPMC K100M (*X* ~2~) and sodium bicarbonate (*X* ~3~) while the dependent variables were % drug release of PSS at 2 h (*Y* ~2~), 4 h (*Y* ~4~) and at 8 h (*Y* ~8~) as shown in Table [1](#T0001){ref-type="table"}. The nonlinear quadratic model by this design is given as \[[@CIT0010]\];$$Yi = b_{0} + b_{1}X_{1} + b_{2}X_{2} + b_{3}X_{3} + b_{12}X_{1}X_{2} + b_{13}X_{1}X_{3} + b_{23}X_{2}X_{3} + b_{11}X_{1}^{2} + b_{22}X_{2}^{2} + b_{33}X_{3}^{2}$$

###### Independent and dependent variables and constrains in box-behnken design.

  Variables                         Level   Constrains        
  --------------------------------- ------- ------------ ---- --------------
  Independent                                                  
  *X*~1~ Sodium alginate (%)        10      25           40   In the range
  *X*~2~ HPMC K100M (%)             6       10           14   In the range
  *X*~3~ Sodium bicarbonate (%)     20      30           40   In the range
  Dependent                                                    
  *Y*~2%~ drug release at 2 h (%)                             20--40
  *Y*~4%~ drug release at 4 h (%)                             40--60
  *Y*~8%~ drug release at 8 h (%)                             80--100

where *Yi* is the measured response of the dependent variables, *b* ~0~ is the intercept, *b* ~1~--*b* ~33~ are the regression coefficients computed from the observed experimental values of *Y*. *X* ~1~, *X* ~2~ and *X* ~3~ are the coded value of the independent variables. *X* ~*a*~ *X* ~*b*~ (*a*, *b* = 1, 2, 3) and $X_{i}^{2}$ (*i* = 1, 2, 3) represent the interaction and quadratic terms, respectively.

### 2.2.2.. Preparation of tablets {#S0006}

Tablets were prepared by mixing PSS, sodium alginate, HPMC K100M (for sustained release effect), sodium bicarbonate, citric acid and calcium carbonate by using sigma mixer and passed through 20-mesh screen. Composition of 15 formulations are given in Table [2](#T0002){ref-type="table"}. Powder blend passed from the micromeritic limits were mixed thoroughly for 5 min by using sigma mixer. The mixture was granulated using 2% (w/w) HPMC E5 in a 90% ethanol solution. 2% (w/w) HPMC E5 in 90% ethanol used as granulating agent. The prepared granules were dried at 40 °C for 2 h, passed through 18-mesh screen.\[[@CIT0004]\] Granules were compressed by using minipress MII (pharma test Hainburg, Germany). Physical tests of tablets such as weight variation, hardness, thickness, diameter and friability were performed.

###### Composition of alginate raft forming tablets.

  Formulation code   PSS (mg)   Sodium alginate (mg)   HPMC K100M (mg)   Sodium bicarbonate (mg)   Citric acid (mg)   Calcium carbonate (mg)   Total weight (mg)
  ------------------ ---------- ---------------------- ----------------- ------------------------- ------------------ ------------------------ -------------------
  AR1                40         40                     56                120                       60                 84                       400
  AR2                40         100                    40                120                       60                 40                       400
  AR3                40         160                    40                100                       50                 10                       400
  AR4                40         40                     40                80                        40                 160                      400
  AR5                40         100                    40                120                       60                 40                       400
  AR6                40         120                    56                100                       50                 34                       400
  AR7                40         100                    24                80                        40                 116                      400
  AR8                40         140                    24                120                       60                 16                       400
  AR9                40         160                    40                80                        40                 40                       400
  AR10               40         100                    24                140                       70                 26                       400
  AR11               40         40                     24                120                       60                 116                      400
  AR12               40         100                    40                120                       60                 40                       400
  AR13               40         80                     56                140                       70                 14                       400
  AR14               40         40                     40                160                       80                 40                       400
  AR15               40         100                    56                80                        40                 84                       400

### 2.2.3.. Effect of pH on raft formation {#S0007}

Prepared tablets were added into 900 ml of simulated gastric fluid (SGF) having pH 1.2, 5.8, 1.0 N HCl pH 1.2 and 0.1 N HCl pH 5.7 and effect of pH on raft formation was observed.\[[@CIT0012]\]

### 2.2.4.. Disintegration time of tablet in water {#S0008}

Disintegration time was measured by placing one tablet in 120 ml of distilled water at room temperature and evaluation of gas around the tablet or its fragments were observed. Tablet was fragmented if the evolution of gas around the tablet or its fragments stopped, being either dissolved or dispersed in water so that no agglomerate remains. The same process was repeated on four additional tablets.\[[@CIT0007]\]

### 2.2.5.. Raft strength {#S0009}

Prepared tablet was transferred to 150 ml of SGF pH 1.2 at 37 °C. SGF was prepared with 2.0 g of sodium chloride, 3.2 g of purified pepsin and 7 ml of HCl in 1000 ml of distilled water. Raft was allowed to form around L-shaped wire probe (diameter: 1.2 mm) held straight in the beaker for 30 min. Raft strength was measured by using the modified balance method.\[[@CIT0013]\]

### 2.2.6.. Volume, weight and thickness of raft {#S0010}

Tablet was transferred to 150 ml of SGF pH 1.2 maintained at 37 °C and wait of 30 min until the raft was formed. Beaker used for raft formation was pre-weighed (*W* ~1~). Top of each raft was observed from outer surface of beaker. The whole weight of beaker and filling was obtained after raft formation (*W* ~2~). Raft was removed from the beaker by pouring off the subnatant liquor and weighed (*W* ~3~). Remaining liquid was removed from the beaker and it was refilled with water to the noticeable position and weighed (*W* ~4~). The volume of each raft was measured in ml and weight was measured in grams.\[[@CIT0005]\] Thickness of raft was measured by placing tablet in 150 ml of SGF. Raft was allowed to form for 10 min and thickness of the raft was measured at three places around the cylinder by using digital vernier caliper (Shandong, China) and expressed as mean value.\[[@CIT0007]\]

### 2.2.7.. Raft resilience {#S0011}

Place one tablet in 150 ml of SGF pH 1.2 at 37 °C in 250 ml glass jar and wait for 30 min until the raft was completely developed. Glass jar was capped and positioned in modified tumble mixer, set to revolve at 20 rpm, to simulate gastric agitation. Raft was assessed visually for such time that a raft could no longer be noticed. A raft was distinct or dispersed into two or more hovering gels at least 15 mm in diameter.\[[@CIT0006]\]

### 2.2.8.. FLT and TFT {#S0012}

USP dissolution apparatus II (pharma test Hainburg, Germany) was used for the determination of FLT and TFT. Add one tablet in 900 ml SGF pH 1.2 maintained at 37 ± 0.5 °C and set at 50 rpm. The time required for raft to rise to the surface and float was determined as FLT. TFT is the total time for which the raft floats in dissolution medium including FLT.\[[@CIT0008]\]

### 2.2.9.. Acid neutralization capacity {#S0013}

The acid neutralization ability of raft forming tablet was estimated using an *in vitro* method. The dissolution apparatus II (paddle method) was operated with a paddle speed of 125 rpm and with 250 ml of 0.02 M HCl solution at 37 °C. Tablet formulation dissolved solution 120 ml was added into the medium and the pH of the medium was checked continuously, after 20 min the burette started with continuous titration of 0.1 M HCl solution at a continual speed of 2.0 ml/min until the acidity of medium reached pH 2.5.Neutralizing and total buffering capacity from pH 2.5--4.5 was calculated by following equations.$$\text{Neutralization\ capacity} = {\lbrack{{({V_{\text{HCl}} \times T_{\text{HCl}}})} + {({V_{tr - 2} \times T_{tr}})}}\rbrack} \times \frac{W1}{W2}$$ $$\text{Buffering\ capacity} = {(V_{tr - 1} \times T_{tr})} \times \frac{W1}{W2}$$

where *V* ~HCl~ is the volume of HCl in the vessel, *T* ~HCl~ the titer of HCl in the vessel, *V* ~*tr*−2~ the added volume of HCl from the burette until pH 2.5, *T* ~tr~ the titer of HCl in the burette, *W* ~1~ the weight of intact formulation and *W* ~2~ the weight of tested quantity of formulation. *V* ~*tr*−1~ is the added volume of HCl from the burette between pH 2.5 and 4.5, *T* ~*tr*~ the titer of HCl in the burette.\[[@CIT0007]\]

### 2.2.10.. *In vitro* drug release studies {#S0014}

The *in vitro* drug release study was carried in 900 ml SGF of pH 1.2 at 37 ± 0.5 °C from 0 to 8 h by using USP dissolution apparatus II at 50 rpm. 5 ml aliquot was pipette out at regular interval and replaced with fresh medium of same volume. The aliquot was filtered by 0.45 μm filter and concentration of drug was determined by UV spectrophotometer (PerkinElmer Inc. New York, USA) at 290 nm.\[[@CIT0014]\]

### 2.2.11.. Drug release kinetics {#S0015}

The mechanisms of controlled release alginate raft forming formulations were determined by different *in vitro* kinetics models such as zero order (Equation 4), first order (Equation 5), higuchi (Equation 6) and Korsmeyer-peppas model (Equation 7).\[[@CIT0015]\]$$F = K_{0}t$$ $$\ln{({1 - F})} = - K_{1}t$$ $$F = K_{2}t^{1/2}$$ $$M_{t/M_{\infty}} = K_{3}t^{n}$$

where *F* is fraction of drug release in time *t*, *K* ~0~ is rate constant for zero order release equation, *K* ~1~ is first order release constant, *K* ~2~ is higuchi constant, *M* ~*t*~ is amount of drug release at time *t*, *M* ~∞~ is amount of drug release at infinity and *n* is diffusion constant.

### 2.2.12.. Fourier transform infrared spectroscopy {#S0016}

FTIR of PSS, sodium alginate, HPMC K100M and raft of optimized formulation AR9 were obtained by FTIR spectrophotometer (Bruker Alpha, Germany) and compared. The spectra was recorded at wavelength range of 800--3500 cm^−1^.

### 2.2.13.. X-ray diffractometry {#S0017}

Crystalline or amorphous nature of drug, polymers, prepared tablets and rafts were evaluated from their diffractograms. Diffractograms of PSS, sodium alginate, HPMC K100M, tablet of optimized formulation AR9 and raft of AR9 optimized formulation were obtained using an XRD diffractometer D/max-2500pc, Rigaku Co, Japan. Tube voltage was 40 kV, current was mA, and scanning rate was 5^0^ over a range of 80--800 diffraction angle.

### 2.2.14.. Differential scanning calorimetry {#S0018}

DSC was used to analyze the thermal characteristics of the powdered sample of drug and polymers, physical mixture, prepared tablets and raft. DSC thermograms of PSS, sodium alginate, HPMC K100M, tablet of optimized formulation and raft of AR9 optimized formulation were obtained by using differential scanning calorimeter DSC-60 Shimadzu, Germany. 5.5 mg sample was placed in aluminum pans, sealed and analyzed under a stream of nitrogen gas of 100 ml/min and heated from 50 to 350 °C.

3.. Results and discussion {#S0019}
==========================

Interaction between independent and dependent variables (Table [3](#T0003){ref-type="table"}) were studied and three dimensional graphs were developed as shown in Figure [1](#F0001){ref-type="fig"}. Disintegration time of tablets and strength, weight, volume and thickness of rafts were within pharmacopoeial limits are mentioned in Table [4](#T0004){ref-type="table"}. Effect of different pH medium on raft formation was studied successfully. Buffering capacity, neutralizing capacity, resilience, FLT and TFT of rafts of all formulations were successfully determined and are shown in Table [5](#T0005){ref-type="table"}. The release pattern of PSS form pectin rafts were determined and are shown in Figure [2](#F0002){ref-type="fig"}. FTIR spectra of PSS, sodium alginate, HPMC K100M and raft of optimized formulation AR9 showed compatibility of PSS with polymers and are shown in Figure [3](#F0003){ref-type="fig"}. DSC thermograms and X-ray diffractograms of PSS, sodium alginate, HPMC K100M, tablet of optimized formulation AR9, and raft of optimized formulation AR9 showed compatibility of drugs with polymers and are shown in Figures [4](#F0004){ref-type="fig"} and [5](#F0005){ref-type="fig"}, respectively.

###### Observed responses for alginate rafts forming tablets (*n* = 6).

  Formulation code   Independent variables   Dependent variables                                        
  ------------------ ----------------------- --------------------- ---- --------------- --------------- ---------------
  AR1                10                      14                    30   24.54 ± 0.011   49.11 ± 0.023   79.78 ± 0.091
  AR2                25                      10                    30   35.43 ± 0.023   60.98 ± 0.982   95.67 ± 0.095
  AR3                40                      10                    25   31.12 ± 0.123   53.89 ± 0.312   90.12 ± 0.011
  AR4                10                      10                    20   41.23 ± 0.093   64.65 ± 0.256   93.11 ± 0.034
  AR5                25                      10                    30   36.87 ± 0.034   59.92 ± 0.095   95.23 ± 0.711
  AR6                30                      14                    25   30.99 ± 0.081   57.78 ± 0.367   79.12 ± 0.098
  AR7                25                      6                     20   47.76 ± 0.456   72.21 ± 0.087   92.68 ± 0.458
  AR8                35                      6                     30   47.34 ± 0.125   75.29 ± 0.087   94.01 ± 0.059
  AR9                40                      10                    20   36.50 ± 0.087   58.89 ± 0.054   98.32 ± 0.911
  AR10               25                      6                     35   44.42 ± 0.056   71.12 ± 0.178   95.32 ± 0.081
  AR11               10                      6                     30   45.67 ± 0.049   68.34 ± 0.034   95.67 ± 0.487
  AR12               25                      10                    30   34.44 ± 0.086   64.55 ± 0.031   94.42 ± 0.043
  AR13               20                      14                    35   25.65 ± 0.056   46.65 ± 0.012   79.35 ± 0.045
  AR14               10                      10                    40   33.99 ± 0.014   58.87 ± 0.054   94.45 ± 0.123
  AR15               25                      14                    20   21.53 ± 0.987   46.55 ± 0.654   81.98 ± 0.014

![3D response surface graph showing effects of sodium alginate (*X* ~1~), HPMC K100M (*X* ~2~) and sodium bicarbonate (*X* ~3~) on (A) % drug release at 2 h (*Y* ~2~), (B) % drug release at 4 h (*Y* ~4~) and (C) % drug release at 8 h (*Y* ~8~).](TDMP_A_1231046_F0001_OC){#F0001}

###### Disintegration time of tablets and strength, weight, volume and thickness of raft (*n* = 6).

  Formulation code   Disintegration time (s)   Raft strength (g)   Raft weight (g)   Raft volume (ml)   Raft thickness (cm)
  ------------------ ------------------------- ------------------- ----------------- ------------------ ---------------------
  AR1                54                        3.19 ± 0.067        1.39 ± 0.012      5.5 ± 0.15         3.5 ± 0.045
  AR2                63                        5.29 ± 0.039        1.84 ± 0.010      7.2 ± 0.05         4.5 ± 0.216
  AR3                57                        7.31 ± 0.012        2.10 ± 0.029      8.9 ± 0.05         5.5 ± 0.136
  AR4                55                        3.10 ± 0.097        1.32 ± 0.011      5.7 ± 0.25         3.9 ± 0.048
  AR5                67                        5.20 ± 0.013        1.85 ± 0.010      7.5 ± 0.15         4.7 ± 0.193
  AR6                65                        7.30 ± 0.067        2.20 ± 0.013      8.4 ± 0.35         5.6 ± 0.085
  AR7                64                        5.59 ± 0.019        1.79 ± 0.011      7.3 ± 0.25         4.7 ± 0.212
  AR8                63                        7.32 ± 0.047        2.00 ± 0.015      8.7 ± 0.15         5.5 ± 0.110
  AR9                64                        7.11 ± 0.010        2.19 ± 0.010      8.8 ± 0.05         5.8 ± 0.245
  AR10               57                        5.10 ± 0.062        1.80 ± 0.034      7.0 ± 0.45         4.3 ± 0.021
  AR11               53                        3.11 ± 0.069        1.23 ± 0.011      5.9 ± 0.85         3.8 ± 0.125
  AR12               57                        5.78 ± 0.067        1.79 ± 0.032      7.9 ± 0.14         4.9 ± 0.211
  AR13               54                        5.61 ± 0.076        1.90 ± 0.021      7.8 ± 0.25         4.7 ± 0.745
  AR14               53                        3.15 ± 0.013        1.11 ± 0.012      5.5 ± 0.15         3.4 ± 0.236
  AR15               59                        5.36 ± 0.063        1.92 ± 0.056      7.6 ± 0.15         4.6 ± 0.045

###### Buffering capacity, neutralizing capacity, resilience, FLT and TFT of raft forming tablets (*n* = 6).

  Formulation code   pH After 4 min   pH After 20 min   Buffering capacity (meq)   Neutralizing capacity (meq)   Raft resilience (min)   FLT (s)   TFT (h)
  ------------------ ---------------- ----------------- -------------------------- ----------------------------- ----------------------- --------- ---------
  AR1                4.1              5.4               11.5 ± 1.01                6.9 ± 0.57                    \>480                   51        \>8
  AR2                4.2              5.5               11.0 ± 1.04                5.5 ± 0.49                    \>480                   52        \>8
  AR3                5.5              6.7               15.7 ± 1.05                7.5 ± 0.31                    \>480                   51        \>8
  AR4                3.5              4.2               10.3 ± 1.81                6.8 ± 0.55                    \>480                   54        \>8
  AR5                4.6              5.6               13.9 ± 1.07                7.6 ± 0.10                    \>480                   52        \>8
  AR6                4.4              5.2               11.5 ± 1.05                5.7 ± 0.49                    \>480                   49        \>8
  AR7                3.2              4.6               10.6 ± 1.91                6.8 ± 0.23                    \>480                   48        \>8
  AR8                4.2              5.8               12.5 ± 1.41                6.7 ± 0.26                    \>480                   50        \>8
  AR9                3.8              4.9               11.2 ± 1.01                6.5 ± 0.56                    \>480                   55        \>8
  AR10               5.7              6.9               14.7 ± 1.05                7.6 ± 0.12                    \>480                   54        \>8
  AR11               4.1              5.0               10.90 ± 1.30               4.9 ± 0.49                    \>480                   49        \>8
  AR12               4.6              5.2               13.69 ± 1.04               7.8 ± 0.16                    \>480                   56        \>8
  AR13               5.0              6.3               12.10 ± 1.10               6.9 ± 0.59                    \>480                   51        \>8
  AR14               5.3              6.5               10.20 ± 1.31               5.8 ± 0.49                    \>480                   53        \>8
  AR15               3.4              4.3               12.70 ± 1.21               7.0 ± 0.34                    \>480                   50        \>8

![Drug release profile of pantoprazole sodium sesquihydrate from alginate rafts (*n* = 6).](TDMP_A_1231046_F0002_B){#F0002}

![FTIR spectra of (A) PSS, (B) sodium alginate, (C) HPMC K100M and (D) alginate raft of optimized formulation AR9.](TDMP_A_1231046_F0003_OC){#F0003}

![DSC thermograms of (A) PSS, (B) sodium alginate, (C) HPMC K100M and (D) tablet of optimized formulation AR9 and (E) alginate raft of optimized formulation AR9.](TDMP_A_1231046_F0004_B){#F0004}

![XRD of (A) PSS, (B) sodium alginate, (C) HPMC K100M and (D) tablet of optimized formulation AR9 and (E) alginate raft of optimized formulation AR9.](TDMP_A_1231046_F0005_B){#F0005}

The outcome of independent variables on dependent variables were studied and 3D plots were developed. Values of % drug release at 2 h were ranged from 21.53 ± 0.987 to 47.76 ± 0.456%. % drug release at 4 and 8 h were found between 46.55 ± 0.654--75.29 ± 0.087 and 79.12 ± 0.098--98.32 ± 0.911%, respectively. All responses were fitted to the quadratic models using BBD. Data of *Y* ~2~, *Y* ~4~ and *Y* ~8~ was observed and best fitted model was quadratic and regression Equations (8--10) were generated.$$Y_{2} = 35.96 + 0.264X_{1} - 7.73X_{2} - 0.83X_{3} - 2.39X_{1}X_{2} - 0.25X_{1}X_{3} + 7.57X_{2}X_{3} + 0.08X_{1}^{2} + 70.05X_{2}^{2} + 0.81X_{3}^{2}$$ $$Y_{4} = 61.19 + 0.29X_{1} - 8.17X_{2} - 0.90X_{3} - 2.94X_{1}X_{2} - 0.32X_{1}X_{3} + 8.99X_{2}X_{3} + 0.10X_{1}^{2} + 81.62X_{2}^{2} + 0.99X_{3}^{2}$$

$$Y_{8} = 95.11 + 0.18X_{1} - 6.58X_{2} - 0.75X_{3} - 1.25X_{1}X_{2} - 0.14X_{1}X_{3} + 5.00X_{2}X_{3} + 0.03X_{1}^{2} + 43.85X_{2}^{2} + 0.57X_{3}^{2}$$

In regression equations positive sign favors the optimization while negative sign indicates an inverse relationship between independent and dependent variables. The amount of sodium alginate (*X* ~1~) HPMC K100M (*X* ~2~) and sodium bicarbonate (*X* ~3~) have different effects on % drug release (*Y* ~2~), (*Y* ~4~) and (*Y* ~8~). Tested formulations showed that percentage of drug release were more when the polymers concentration were less as compared to the formulation contained high amount of polymers. When the concentration of sodium alginate and HPMC K100M were 25 and 10%, respectively the sustained release effect of drug from alginate rafts were good but below that concentrations the drug was rapidly released and above that concentrations the release of drug was slow. The interaction of *X* ~1~ and *X* ~2~ was insignificant and showed negative effect on *Y* ~2~, *Y* ~4~ and *Y* ~8~ and *X* ~1~ and *X* ~3~ possessed negative value and have insignificant effect on *Y* ~2~, *Y* ~4~ and *Y* ~8~. Interaction of *X* ~2~ and *X* ~3~ was significant and have positive effect on *Y* ~2~, *Y* ~4~ and *Y* ~8~. Optimized formulation AR9 was selected on the basis of better release pattern of drug at 2, 4 and 8 h. Rapolu et al. studied the effect of different polymer concentrations on release profile of GRRD of metronidazole by using BBD.\[[@CIT0009]\]

At pH 1.2 of SGF and 1.0NHCl tablets rapidly disintegrated and rafts were formed on the top of medium but at pH 5.7 of 0.1N HCl and 5.8 of SGF, tablets were reside at the bottom of the medium and rafts were not formed. Elliot et al. studied the effect of different pH medium on raft forming alginate-antacids combined formulations.\[[@CIT0012]\]

Disintegration time of tablets of 15 formulations were ranged from 53 to 67 s. Effects of concentration of sodium alginate and sodium bicarbonate on disintegration time of tablets were observed. Formulations (AR1, AR4, AR11 and AR14) containing less amount of sodium alginate showed less disintegration time of tablets as compared to the formulations (AR3, AR6, AR8 and AR9) containing high amount of sodium alginate as shown in Table [3](#T0003){ref-type="table"}. Formulations (AR3, AR10, AR13 and AR14) containing higher concentration of sodium bicarbonate rapidly disintegrate as compared to the formulations (AR5, AR6 and AR7) having less amount of sodium bicarbonate. Jang et al. studied the disintegration time of risedronate sodium tablets in water containing sodium alginate as a raft forming polymer and sodium bicarbonate as gas generating substances.\[[@CIT0007]\]

Raft strength was ranged from 3.10 ± 0.097 to 7.32 ± 0.047 g measured by modified balance method as shown in Table [3](#T0003){ref-type="table"}. Raft weight and volume was ranged from 1.11 ± 0.012 to 2.20 ± 0.013 g and 5.5 ± 0.15 to 8.9 ± 0.05 ml, respectively. Hampson et al. measured the strength, weight and volume of rafts of sodium alginate.\[[@CIT0005]\] Raft thickness ranged from 3.4 ± 0.236 to 5.8 ± 0.245 cm as mentioned in Table [3](#T0003){ref-type="table"}. AR14 formulation showed less thickness of raft due to less amount of polymers but AR9 formulation has highest raft thickness because of maximum amount of polymers.\[[@CIT0007]\] Thickness of raft was increased when the concentration of the polymers were increased. Raft resilience of all formulations were greater than 480 min as shown in Table [4](#T0004){ref-type="table"}.\[[@CIT0016]\] Hampson et al. measured the resilience of alginate rafts and studied the effect of polymer concentration on resilience of rafts.\[[@CIT0005]\] FLT was ranged from 48 to 55 s, AR9 formulation showed maximum FLT and AR7 showed the minimum value as shown in Table [5](#T0005){ref-type="table"}. TFT of all prepared formulations was found to be greater than 8 h.

An *in vitro* method reported by Jang et al. \[[@CIT0007]\] were used to check the buffering and neutralizing capacity. pH values after 4 and 20 min were recorded as mentioned in Table [5](#T0005){ref-type="table"}. The formulations containing the maximum amount of sodium citrate and citric acid possessed higher buffering between pH 2.5--4.5 and neutralizing capacity. The pH after 4 and 20 min checks an un-physiologically high pH and neutralizing capacity between 2.5 and 4.5 is sign for the efficacy in the physiological environment.

The drug release from alginate rafts forming formulations AR1--AR15 were investigated. The concentration of sodium alginate was ranged from 10 to 40% have an effect on release of drug from raft. When the amount of sodium alginate was increased the release of PSS from raft was decreased. PSS is freely water soluble, a retardant HPMC K100M was added to sustain the release pattern of drug from raft. HPMC K100M form a gel barrier around raft that allows the drug to be released by diffusion process. HPMC K100M was used the concentration ranges of 6--14%. As predictable, on increasing the concentration of HPMC K100M, the thickness of gel barrier was increased that delayed the release of PSS from raft. He et al. studied the effect of effect of HPMC K100 on release profile of metformin.\[[@CIT0004]\] Sodium bicarbonate 20--40% a gas generating substance also have effect on drug release from raft.\[[@CIT0017]\] Sodium bicarbonate generate carbon dioxide after reacting with acidic dissolution medium and resulted in the form of gel like raft system at the surface of the medium. The carbon dioxide is entrapped in the gel cause obstruction of diffusion pathway of drug release from raft. This effect was more observed at low polymer concentrations in the formulation (AR1, AR13). When the polymer concentrations were increased in the formulation (AR2, AR5, AR9) the effect of sodium bicarbonate on drug release from alginate raft was decreased. Jiménez-Martínez et al. studied the effect of sodium bicarbonate on release profile of captopril from floating matrix tablets.\[[@CIT0018]\] The drug release percentages after 2, 4 and 8 h were mentioned in Table [2](#T0002){ref-type="table"}. The optimized formulation AR9 showed optimum drug release i.e. 98%.

In kinetic release models *R* ^2^ values of zero order release were ranged from 0.711 to 0.981 while in first order release it was 0.957--0.990 and which observed the concentration dependent release of PSS. In korsmeyer-peppas model value of n was found to be 0.57 which was greater than 0.45 showing a non-fickian drug release mechanism in prepared formulations. Jose et al. studied the release pattern of insulin from tablets of crosslinked chitosan microspheres by using korsmeyer-peppas.\[[@CIT0019]\]

FTIR spectra of PSS showed its features peaks at 1587.83, 1301.87, 1104.89 cm^−1^ due to C=C stretching, C--N stretching and C--F stretching, respectively.\[[@CIT0020]\] Sodium alginate showed peaks at 1583.96, 1406.68 cm^−1^ provide information about water and carboxylic group of alginate and 1022.38 cm^−1^ due to --OH bending vibration.\[[@CIT0021]\] HPMC K100M showed two peaks at 1054.87 and 3400.03 cm^−1^ due to C--O and O--H stretching vibrations respectively.\[[@CIT0022]\]). Raft of AR9 formulation showed peaks at 3223.09, 1688.17, 1586.67^−1^, 1302.64^−1^, 1162.01^−1^,and 1027.74 cm^−1^ due to --OH stretching, ester carbonyl group (C=O) stretching, existence of water and carboxylic group in raft, C--N stretching, C--F stretching and --OH bending vibration. The FTIR spectra of drug, polymers and raft of AR9 formulation showed no notable interaction between them. Spectra of raft of AR9 formulation showed the presence of sodium alginate, HPMC K100M and drug were effectively entrapped in the pectin raft.

DSC thermograms of PSS, sodium alginate, HPMC K100M, tablet of optimized formulation AR9 and raft of AR9 formulation are shown in Figure [4](#F0004){ref-type="fig"}. Thermogram of PSS showed an endothermic peaks at 250 °C which was the indication of melting point of PSS.\[[@CIT0023]\] Thermograms of sodium alginate, HPMC K100M, tablet of optimized formulation AR9 and raft of AR9 optimized formulation showed no peaks indicating that PSS was dispersed in the tablet and raft effectively.

XRD diffractograms showed characteristics diffraction lines of PSS at 2*θ* of 6°and 22° due to its crystalline nature are shown in Figure [5](#F0005){ref-type="fig"}.\[[@CIT0023]\] Sodium alginate showed well defined peaks at 3° (2*θ*) related to its crystallinity due to strong intermolecular hydrogen bonding \[[@CIT0024]\] and HPMC K100M at 3°, 9° and 18° (2*θ*).\[[@CIT0025]\] The diffractograms of tablet of optimized formulation AR9 and raft of AR9 optimized formulation showed many characteristics peaks at 15°, 17°, 19°, 27°, 32° and 40° (2*θ*) but disappearance of the peaks of PSS, sodium alginate and HPMC K100M were observed. This indicated that the crystalline nature of PSS was decreased after tablet preparation and raft formation of AR9 optimized formulation.

4.. Conclusion {#S0020}
==============

Raft forming tablets were successfully developed using sodium alginate as raft forming polymers, HPMCK100M for sustained effect, sodium bicarbonate and citric acid as gas generating agents and neutralizing agent calcium carbonate. This novel oral dosage form rapidly disintegrate and formed floating raft on the surface of SGF, preventing reflux disorders associated with peptic ulcer and release the PSS up to 8 h. The raft floats on the surface of SGF for up to 24 h with 1 min of FLT. *In vitro* modified balance method for measurement of raft strength was developed successfully. Optimized formulation AR9 showed good strength, thickness and resilience of raft.
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